L M Howard, H Markus. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » HumansIntestinal Pseudo-Obstruction/chemically inducedLofepramine/adverse effectsMaleMandelic Acids/adverse effectsMiddle AgedParasympatholytics/adverse effectsParkinson Disease/drug therapy
Substances: See more » Mandelic AcidsParasympatholyticsoxybutyninLofepramine
Year: 1992 PMID: 1561204 PMCID: PMC2399308 DOI: 10.1136/pgmj.68.795.70
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401